ATENASTOBART
UNII JXF4U92TC9

Substance Identification & Data

This profile provides standardized clinical and technical data for Atenastobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JXF4U92TC9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2817644-49-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
JXF4U92TC9
CAS Registry Number
2817644-49-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ATENASTOBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211775
National Cancer Institute reference terminology for clinical and research data.
INN ID
12848
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atenastobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATENASTOBART

Common Names & Synonyms

ATENASTOBART [INN]
H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-450) (VH (HOMO SAPIENS IGHV3-21*01 (90.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.15) (26-33.51-58.97-111)) (1-122) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, G1V85 CH2 W1.2, N1.1, D30, K115, G1V87 CH2 R94, CH3 R1.2 (CH1 R120 (219) (123-220), HINGE 1-15 (221-235), CH2 L1.2>W (240), G1.1>N (241), H30>D (273), Q94>R (316), A115>K (335) (236-345), CH3 E12 (361), M14 (363), P1.2>R (348) (346-450), CHS G1>DEL, K2>DEL) (123-450)), (225-215')-DISULFIDE WITH L-LAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'-216') (V-LAMBDA (HOMO SAPIENS IGLV2-8*01 (93.5%) -IGLJ3*02 (100%), CDR-IMGT (9.3.10) (26'-34'.52'-54'.91'-100')) (1'-110') -HOMO SAPIENS IGLC2*01 (100%) (C-LAMBDA2) (111'-216')); DIMER (231-231'':234-234'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DXB11, GLYCOFORM ALFA
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS TNFRSF9 (TNF RECEPTOR SUPERFAMILY MEMBER 9, 4-1BB, T CELL ANTIGEN ILA, CD137)), HOMO SAPIENS MONOCLONAL ANTIBODY

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus